Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.

Authors

Bahey Salem
Samantha Miner
Nancy F Hensel
Minoo Battiwalla
Keyvan Keyvanfar
David F Stroncek
Adrian P Gee
Patrick J. Hanley, George Washington UniversityFollow
Catherine M. Bollard, George Washington UniversityFollow
Sawa Ito
A John Barrett

Document Type

Journal Article

Publication Date

12-1-2015

Journal

Cytotherapy

Volume

17

Issue

12

Inclusive Pages

137-145

DOI

10.1001/jamaophthalmol.2015.4606

Keywords

Diabetes Mellitus, Type 1--drug therapy; Diabetic Retinopathy--physiopathology; Hypoglycemic Agents--therapeutic use; Insulin--therapeutic use; Visual Acuity--physiology

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Salem, B., Miner, S., Hensel, N., Battiwalla, M., Keyvanfar, K., Stroncek, D., Gee, A., Hanley, P. J., Bollard, C. M., Ito, S., & Barrett, A. (2015). Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.. Cytotherapy, 17 (12). http://dx.doi.org/10.1001/jamaophthalmol.2015.4606

Peer Reviewed

1

Open Access

1